Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung

Journal of Lipid Research

Volumn 51, Issue 9, 2010, Pages 2560-2570

  Wang, Weiling ^a,b,c   Xu, Hao ^a   Shi, Yang ^a   Nandedkar, Sandhya ^a   Zhang, Hao ^a   Gao, Haiqing ^b,c   Feroah, Thom ^a   Weihrauch, Dorothee ^a   Schulte, Marie L ^a   Jones, Deron W ^a   Jarzembowski, Jason ^a   Sorci Thomas, Mary ^d   Pritchard Jr , Kirkwood A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b SHANDONG UNIVERSITY   (China)

^c Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

3 nitrotyrosine; 4 hydroxy 2 nonenal; High density lipoprotein; Myeloperoxidase; Pro inflammatory HDL; TGF 1; Vasodilatation; Xanthine oxidase

Indexed keywords

2 HYDROXY 2 NONENAL; 3 NITROTYROSINE; APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE 1; COLLAGEN; DICHLORODIHYDROFLUORESCEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; NITRATE; NITRITE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; ENZYME ACTIVITY; FACIALIS ARTERY; GENE DELETION; GENE FUNCTION; INFLAMMATION; INFLAMMATORY CELL; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPID STORAGE; LUNG ARTERY; LUNG FUNCTION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; VASODILATATION;

ANIMALS; APOLIPOPROTEIN A-I; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHOLESTEROL, HDL; COLLAGEN; GENE DELETION; INFLAMMATION; LIPID METABOLISM; LUNG; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; VASODILATION;

EID: 77956861083     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M004549     Document Type: Article

References (49)

1. Bates, S. R., J. Q. Tao, H. L. Collins, O. L. Francone, and G. H. Rothblat. 2005. Pulmonary abnormalities due to ABCA1 deficiency in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L980-L989.
2. Yuditskaya, S., A. Tumblin, G. T. Hoehn, G. Wang, S. K. Drake, X. Xu, S. Ying, A. H. Chi, A. T. Remaley, R. F. Shen, et al. 2009. Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood. 113: 1122-1128.
3. Otera, H., T. Ishida, T. Nishiuma, K. Kobayashi, Y. Kotani, T. Yasuda, R. K. Kundu, T. Quertermous, K. Hirata, and Y. Nishimura. 2009. Targeted inactivation of endothelial lipase attenuates lung allergic inflammation through raising plasma HDL level and inhibiting eosinophil infiltration. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L594-L602.
4. Ansell, B. J., G. C. Fonarow, and A. M. Fogelman. 2006. High-density lipoprotein: is it always atheroprotective? Curr. Atheroscler. Rep. 8: 405-411.
5. Ansell, B. J., M. Navab, S. Hama, N. Kamranpour, G. Fonarow, G. Hough, S. Rahmani, R. Mottahedeh, R. Dave, S. T. Reddy, et al. 2003. Inflammatory/ antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 108: 2751-2756.
6. Nicholls, S. J., L. Zheng, and S. L. Hazen. 2005. Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc. Med. 15: 212-219.
7. Watanabe, J., K. J. Chou, J. C. Liao, Y. Miao, H. H. Meng, H. Ge, V. Grijalva, S. Hama, K. Kozak, G. Buga, et al. 2007. Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis. J. Biol. Chem. 282: 23698-23707.
8. Van Lenten, B. J., S. Y. Hama, F. C. de Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96: 2758-2767.
9. Ohno, I., Y. Nitta, K. Yamauchi, H. Hoshi, M. Honma, K. Woolley, P. O'Byrne, G. Tamura, M. Jordana, and K. Shirato. 1996. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am. J. Respir. Cell Mol. Biol. 15: 404-409.
10. Minshall, E. M., D. Y. Leung, R. J. Martin, Y. L. Song, L. Cameron, P. Ernst, and Q. Hamid. 1997. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17: 326-333.
11. Smith, L. J., M. Shamsuddin, P. H. Sporn, M. Denenberg, and J. Anderson. 1997. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic. Biol. Med. 22: 1301-1307.
12. De Sanctis, G. T., J. A. MacLean, K. Hamada, S. Mehta, J. A. Scott, A. Jiao, C. N. Yandava, L. Kobzik, W. W. Wolyniec, A. J. Fabian, et al. 1999. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J. Exp. Med. 189: 1621-1630.
13. Onufrak, S., J. Abramson, and V. Vaccarino. 2007. Adult-onset asthma is associated with increased carotid atherosclerosis among women in the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 195: 129-137.
14. Ou, J., J. Wang, H. Xu, Z. Ou, M. G. Sorci-Thomas, D. W. Jones P. Signorino, J. C. Densmore, S. Kaul, K. T. Oldham, et al. 2005 Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet. Circ. Res. 97 1190-1197.
15. Aviram, M., S. Billecke, R. Sorenson, C. Bisgaier, R. Newton, M. Rosenblat, J. Erogul, C. Hsu, C. Dunlop, and B. La Du. 1998 Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler. Thromb. Vasc. Biol. 18: 1617-1624.
16. Ou, Z., J. Ou, A. W. Ackerman, K. T. Oldham, and K. A. Pritchard Jr. 2003. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells. Circulation. 107: 1520-1524.
17. Braman, R. S., and S. A. Hendrix. 1989. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal. Chem. 61: 2715-2718.
18. Konduri, G. G., I. Bakhutashvili, A. Eis, and K. Pritchard, Jr. 2007 Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 292: H1812-H1820.
19. Gomes, R. F., X. Shen, R. Ramchandani, R. S. Tepper, and J. H. Bates. 2000. Comparative respiratory system mechanics in rodents. J. Appl. Physiol. 89: 908-916.
20. Hantos, Z., A. Adamicza, E. Govaerts, and B. Daroczy. 1992 Mechanical impedances of lungs and chest wall in the cat. J. Appl. Physiol. 73: 427-433.
21. Tomioka, S., J. H. Bates, and C. G. Irvin. 2002. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J. Appl. Physiol. 93: 263-270.
22. Finotto, S., M. F. Neurath, J. N. Glickman, S. Qin, H. A. Lehr, F. H. Green, K. Ackerman, K. Haley, P. R. Galle, S. J. Szabo, et al. 2002 Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 295: 336-338.
23. Ingenito, E. P., S. H. Loring, M. L. Moy, S. J. Mentzer, S. J. Swanson, A. Hunsaker, C. C. McKee, and J. J. Reilly. 2001 Comparison of physiological and radiological screening for lung volume reduction surgery. Am. J. Respir. Crit. Care Med. 163 1068-1073.
24. Pritchard, K. A., Jr., J. Ou, Z. Ou, Y. Shi, J. P. Franciosi, P. Signorino, S. Kaul, C. Ackland-Berglund, K. Witte, S. Holzhauer et al. 2004. Hypoxia-induced acute lung injury in murine models of sickle cell disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 L705-L714.
25. Weihrauch, D., H. Xu, Y. Shi, J. Wang, J. Brien, D. W. Jones, S. Kaul R. A. Komorowski, M. E. Csuka, K. T. Oldham, et al. 2007. Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation and angiogenic potential in Tight-skin mice. Am. J. Physiol. Heart Circ. Physiol. 293: H1432-H1441.
26. Navab, M., S. Y. Hama, G. P. Hough, G. Subbanagounder, S. T. Reddy, and A. M. Fogelman. 2001. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J. Lipid Res. 42: 1308-1317.
27. Williamson, R., D. Lee, J. Hagaman, and N. Maeda. 1992. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc. Natl. Acad. Sci. USA 89: 7134-7138.
28. Plump, A. S., N. Azrolan, H. Odaka, L. Wu, X. Jiang, A. Tall, S. Eisenberg, and J. L. Breslow. 1997. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes. J. Lipid Res. 38: 1033-1047.
29. Nandedkar, S. D., T. R. Feroah, W. Hutchins, D. Weihrauch, K. S. Konduri, J. Wang, R. C. Strunk, M. R. DeBaun, C. A. Hillery and K. A. Pritchard. 2008. Histopathology of experimentally induced asthma in a murine model of sickle cell disease. Blood. 112 2529-2538.
30. Navab, M., G. M. Anantharamaiah, S. Hama, D. W. Garber, M. Chaddha, G. Hough, R. Lallone, and A. M. Fogelman. 2002. Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 105: 290-292.
31. Ou, J., Z. Ou, D. W. Jones, S. Holzhauer, O. A. Hatoum, A. W. Ackerman, D. W. Weihrauch, D. D. Gutterman, K. Guice, K. T. Oldham, et al. 2003. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. Circulation. 107: 2337-2341.
32. Feingold, K. R., R. A. Memon, A. H. Moser, and C. Grunfeld. 1998. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis. 139: 307-315.
33. Peterson, T. E., V. Poppa, H. Ueba, A. Wu, C. Yan, and B. C. Berk. 1999. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ. Res. 85: 29-37.
34. Hirai, T., and J. H. Bates. 2001. Effects of deep inspiration on bronchoconstriction in the rat. Respir. Physiol. 127: 201-215.
35. Hirai, T., K. A. McKeown, R. F. Gomes, and J. H. Bates. 1999. Effects of lung volume on lung and chest wall mechanics in rats. J. Appl. Physiol. 86: 16-21.
36. Irvin, C. G., and J. H. Bates. 2003. Measuring the lung function in the mouse: the challenge of size. Respir. Res. 4: 4.
37. Beckman, J. S., and W. H. Koppenol. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271: C1424-C1437.
38. Halliwell, B. 1997. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett. 411: 157-160.
39. Eiserich, J. P., M. Hristova, C. E. Cross, A. D. Jones, B. A. Freeman, B. Halliwell, and A. van der Vliet. 1998. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 391: 393-397.
40. Liu, J., A. Ormsby, N. Oja-Tebbe, and P. J. Pagano. 2004. Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy. Circ. Res. 95: 587-594.
41. Binder, C. J., K. Hartvigsen, M. K. Chang, M. Miller, D. Broide, W. Palinski, L. K. Curtiss, M. Corr, and J. L. Witztum. 2004. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114: 427-437.
42. Daugherty, A., D. L. Rateri, and V. L. King. 2004. IL-5 links adaptive and natural immunity in reducing atherosclerotic disease. J. Clin. Invest. 114: 317-319.
43. White, C. R., V. Darley-Usmar, W. R. Berrington, M. McAdams, J. Z. Gore, J. A. Thompson, D. A. Parks, M. M. Tarpey, and B. A. Freeman. 1996. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc. Natl. Acad. Sci. USA. 93: 8745-8749.
44. Aslan, M., T. M. Ryan, B. Adler, T. M. Townes, D. A. Parks, J. A. Thompson, A. Tousson, M. T. Gladwin, R. P. Patel, M. M. Tarpey, et al. 2001. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc. Natl. Acad. Sci. USA. 98: 15215-15220.
45. Aslan, M., and B. A. Freeman. 2004. Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease-mechanisms and consequences. Cell Mol. Biol. (Noisy-le-grand). 50: 95-105.
46. Bellocq, A., E. Azoulay, S. Marullo, A. Flahault, B. Fouqueray, C. Philippe, J. Cadranel, and L. Baud. 1999. Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am. J. Respir. Cell Mol. Biol. 21: 128-136.
47. Poss, W. B., T. P. Huecksteadt, P. C. Panus, B. A. Freeman, and J. R. Hoidal. 1996. Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia. Am. J. Physiol. 270: L941-L946.
48. Papi, A., M. Contoli, P. Gasparini, L. Bristot, M. R. Edwards, M. Chicca, M. Leis, A. Ciaccia, G. Caramori, S. L. Johnston, et al. 2008. Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells. J. Biol. Chem. 283: 28595-28606.
49. Ozaki, M., S. Kawashima, T. Yamashita, T. Hirase, M. Namiki, N. Inoue, K. Hirata, H. Yasui, H. Sakurai, Y. Yoshida, et al. 2002. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J. Clin. Invest. 110: 331-340.